Introduction
============

Cancer research has generated a rich and complex body of knowledge, revealing cancer to be a disease involving dynamic changes in the genome.[@b1-cin-6-0389] Research over the past decades has revealed a number of molecular, biochemical, and cellular traits shared by most and perhaps all types of human cancer.[@b2-cin-6-0389] However, today there is a need to look at all cancers from different perspectives, using genomic[@b1-cin-6-0389],[@b3-cin-6-0389] and proteomic[@b4-cin-6-0389],[@b5-cin-6-0389] molecular techniques and try to achieve results in ways that never seemed possible.[@b6-cin-6-0389]

Lung cancer remains the leading cause of cancer death in industrialized countries, claiming more than 150,000 lives annually in the US.[@b7-cin-6-0389] The overall 10-year survival rate is a staggering 8%--10%,[@b8-cin-6-0389] and it is currently impossible to identify the high-risk patients.[@b9-cin-6-0389] Today, lung carcinoma classification is based on clinicopathology. The subclassification of lung cancers is very challenging, and studies have shown that different pathologists have differed on subclassification of the same carcinomas more than half of the time.[@b10-cin-6-0389] Determining metastasis of non-lung origin from lung adenocarcinomas is also difficult.[@b11-cin-6-0389],[@b12-cin-6-0389] A broader basis of the molecular biology of lung carcinomas could help aid in prediction of outcome, choice of therapies, and identification of new biomarkers.[@b13-cin-6-0389]

Microarray technology has made it possible for researchers to search for molecular markers of most cancers.[@b14-cin-6-0389]--[@b20-cin-6-0389] A number of lung cancer studies have settled upon variable numbers in different sets of genes for successful prognostic classifiers, including Xi et al.[@b21-cin-6-0389] (318 genes), Lu et al.[@b22-cin-6-0389] (64 genes), Sun et al.[@b23-cin-6-0389] (50 genes), Jiang et al.[@b24-cin-6-0389] (36 genes), Bianchi et al.[@b25-cin-6-0389] (10 genes), Chen et al.[@b26-cin-6-0389] (5 genes), and Lau et al.[@b27-cin-6-0389] (3 genes). The resulting classifiers may be used in all areas of prediction such as detection, choice of therapy, metastasis, and survival outcomes. While many of these models may exhibit very good accuracy, none have been clinically implemented.

By making their datasets publicly available, researchers provide opportunities for re-analysis of their data by others, including the opportunity for the comparison of a variety of distinct approaches to analysis. New methods of analysis can be developed and evaluated, hopefully leading to improvements in our understanding of the differences in the performance of distinct methods. In this study, we have re-analyzed the publicly available lung adenocarcinoma datasets of Beer et al.[@b9-cin-6-0389] and Bhattacharjee et al.[@b13-cin-6-0389] (both extensively studied at CAMDA 2003 conference; <http://www.camda.duke.edu/camda03.html>). Additionally, Efficiency Analysis was also performed using data from the Guo et al.[@b28-cin-6-0389] rat toxicogenomic study data (MAQC Project). We will not try to duplicate or scrutinize their results, but rather use their data to assess a variety of analysis methods.

It is important to mention that the word 'efficiency' is used in statistics for describing the relative size of the variance of an estimator to a fully efficient estimator like the maximum likelihood. We introduce the concept of an empirical method to study efficiency through the consistency of statistical inferences made with any estimator. The term here is used in a slightly more generic manner as the relative internal consistency at a particular sample size. Methods that show higher internal consistency at a small *N* have more apparent power, and are therefore more efficient because they require lower *N* to achieve the same or higher observed degree of internal consistency compared to methods that require larger *N*.

Materials and Methods
=====================

Data retrieval
--------------

Portions of both datasets, Beer, et al. and Bhattacharjee, et al. are already available on the caGEDA website (<http://bioinformatics2.pitt.edu/GE2/GEDA.html>),[@b29-cin-6-0389] and the data can also be obtained by links from the subsequent journal articles.[@b9-cin-6-0389],[@b13-cin-6-0389] Each dataset contained 5377 genes. The Beer dataset used contains data from 69 neoplastic lung adenocarcinoma samples and 17 non-neoplastic samples. The Bhattacharjee dataset used contained 52 neoplastic and 17 non-neoplastic samples. The datasets used either the Affymetrix HUGeneFL or the HG_U95Av2 microarray chip platforms, respectively. Probe sets were merged by joining Unigene cluster ID's.

Data and statistical analysis
-----------------------------

All test, normalization, and transformation analyses were performed using caGEDA, a freely available informatics tool. The datasets were analyzed for differentially expressed genes (DE genes). Efficiency Analysis was performed followed by Random Resampling Validation (RRV) using a Naïve Bayes Classifier, and PACE Analysis (all described below).

Efficiency analysis
-------------------

Efficiency Analysis is a new method for comparing the apparent internal, or external, consistency in the list of genes found by competing methods for feature selection. In its current application, Efficiency Analysis is implemented as a method that compares the differences in the percentage of overlap of two or more methods found at the same numerical index (number) of overlapping genes, in randomly split datasets. For example, a method that exhibits 50% overlap in the 100 top genes from two studies should be preferred to a method that exhibits 5% overlap in the top 100 genes. For any test (using the same starting list), the lists overlap is 100% when all genes are included (no feature selection), assuming the same chip content. As one applies increasing stringency to the criterion for feature selection to two datasets, the number of genes that are retained decreases, and therefore the number that overlap between the two lists decreases. For any method that is less than perfectly consistent, the proportion of overlap decays as well (as the number of genes approaches zero). Methods exhibiting the highest percent overlap, at a given threshold of a filter or test, (which defines that number of genes in the observer overlap), are considered the most efficient. For internal Efficiency Analysis, a dataset of *N* samples is split into *n* non-overlapping sets, each with *N*/*n* samples. For external Efficiency Analysis, two (or more) independent datasets are generated that address the same biological or clinical question. In either case (internal or external), a given test T (t-, F-, fold-change, etc) is applied to all genes in each dataset separately. The threshold (cut-point) associated with significance level is increased in a stepwise manner over the range of significance levels (thresholds) for the test in *n* datasets. The percent overlap (O) in the independently determined ranked gene lists is determined at each threshold value (O is the relative size of the area of the overlap to the non-overlap in a Venn diagram ([Fig. 1](#f1-cin-6-0389){ref-type="fig"}). N1 and N2 are the number of genes found to be significant at a given threshold value in dataset 1 and 2, respectively, and N3 is the number of genes in the intersection of the datasets (size of overlap, then O = N3/(N1 + N2 − N3). Plotting O VS. N3 creates an 'efficiency curve' for a given test ([Fig. 2](#f2-cin-6-0389){ref-type="fig"}). For all values of N3≪M (the total number of genes), the test (t-, F-, fold-change, etc.) with the highest O at a given N3 is said to be the most efficient. For any given test, the threshold associated with N3≪M associated with the highest O is speculated to be optimal for that test. This approach does not attempt to estimate the false discovery rate (FDR; expected ratio of false positives among the significant results) but instead uses empirical consistency to guide researchers in the selection of competing diverse methods. The curve also may point to a test-threshold that exhibits increased local efficiency.

Initially, each dataset was split randomly into four representative groups; with each containing at least four normal samples and with one of the four groups containing five normals. Internal Efficiency Analysis was performed within each dataset using the Efficiency Analysis option in caGEDA ('internal Efficiency Analysis'). For all of the tests described in this paper, external Efficiency Analysis was also performed using completely independent datasets ('external Efficiency Analysis'). External efficiency curves were generated by pasting the ranked gene lists, with their associated test scores, into the Overlap4 tool <http://bioinformatics.pitt.edu/GE2/Overlap4.html> with a step of 0.1. The final gene list contains: 1) percentage of overlap (O) at a given threshold, for a specified number of genes (N3), and 2) for each selected gene, the percentage for degree of differential expression. As an independent check on the potential utility of the various gene lists, all tests were assessed for classification error using internal cross-validation (RRV with a 70%--30% split, performed at 100 iterations) with a Naïve Bayes classifier over the range of significance level for each test.

Tests for differential expression
---------------------------------

### Lung cancer data

Detailed descriptions about the tests examined can be found on the caGEDA website (<http://bioinformatics2.pitt.edu/GE2/GEDA.html>)[@b29-cin-6-0389] and some brief descriptions of the threshold-based tests and normalization methods are described in [Appendix A](#app1-cin-6-0389){ref-type="app"}. For most tests, a threshold of 0 was used for all tests so that all genes were returned with a score. Random Feature Selection (RFS) used a threshold range that spanned from 0 to the total number of genes (5377 distinct genes) to produce an appropriate and comparable result. PPST[@b30-cin-6-0389] and SAM[@b31-cin-6-0389] are permutation tests and were performed as such using the following settings: PPST using 100 permutations, threshold 1, and 1--99 quantiles; SAM using 100 permutations, δ of −1, and a δ′ of 0. The Segmented J5, described here for the first time, used 100 percentiles and a threshold of 0 for analysis. Any missing values were estimated using the K-Nearest Neighbor method with 3 neighbors.[@b32-cin-6-0389] Non-distinct gene values were averaged. For initial assessment of the tests, no normalization/transformation method was used. For the normalizations/transformations, the best performing test within the acceptable gene number range, D1, was used to find the best accompanying normalization/transformation method.

### Rat toxicogenomic data

Data were obtained from the MAQC Project website (<http://www.fda.gov/nctr/science/centers/toxicoinformatics/maqc/>). Efficiency Analysis was performed for the desired tests using caGEDA and parameters described above for internal Efficiency Analysis and the individual tests. Because the distributed data were previously normalized and filtered by the authors,[@b28-cin-6-0389] additional normalizations were not performed in assessing the tests. Results from the J5 family, fold-change family, t-test, and random feature selection were compared.

Naïve Bayes classification error estimation
-------------------------------------------

Random Resampling Validation (RRV) was performed on the Beer et al. dataset with the Naïve Bayes classifier to produce internal cross-validation estimates of classifier performance characteristics. As a preliminary assessment of the variation in performance associated with different normalization methods, the D1 test was used in combination with transformation/normalization methods. The following parameters were used: Mean as a measure of central tendency, Naïve Bayes Classifier with the proportion of samples as the prior, 100 iterations, a 70%--30% training/test split, and a threshold range of 0 to 50 with a 1.0 step. The Bhattacharjee dataset threshold ranged from 0 to 1 with a step of 0.01. Unfortunately, tests that implement permutations (SAM and PPST) were not performed using RRV because caGEDA can not perform both resampling and randomization in stages simultaneously. Similar ranges and steps were used for the normalization methods, and a similar number of iterations were used in choosing the steps for the exceptions. The optimal threshold value was used for the classification of the initial training/test set. The selected gene list, under the most efficient normalization and test combination, was used to predict sample class labels using the Naïve Bayes Classifier. Importantly, reciprocal external cross-validation was performed for each data set i.e. one dataset was used for training, and then tested on the other, and vice-versa.

Pace analysis
-------------

Additional computational validation was performed using PACE Analysis.[@b33-cin-6-0389] Permutation Achieved Classification Error (PACE) uses permutations of the given data set to determine if the achieved classification errors are significant at the 95% and 99% levels.

Intensity-related bias
----------------------

As our study proceeded, we observed an apparent signal intensity-related bias of the J5 and derived tests toward the high end of the intensity range. Other tests appear to favor genes either at the low end, or in the mid-intensity range. To evaluate the impact of this problem, and the effects of other potential intensity-related biases, we rescaled each gene by the formula:

new_value = (old_value−min_value)/(max_value−min_value) across all of the chips (within genes) and repeated Efficiency Analysis on all methods.

J5 Test
-------

The J5 test is a gene-specific ratio between the mean difference in expression intensity between two groups, A and B, to the average mean group difference of all M genes. The J5 is intended for use when t-tests are likely to exhibit unacceptably low specificity (high false discovery rates) due to unstable estimates of the variance.[@b29-cin-6-0389] For a two-group (A v B) comparison, the J5 test is described for the *i*^th^ of m genes as:
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Segmented J5
------------

The Segmented J5 genes are ranked by median intensity and the entire distribution is divided into quantiles (default 100). We then used the mean parameter estimates from within each quantile separately, therefore eliminating the signal intensity bias. The mean of the absolute value of the difference of means within a quantile is used for each gene as the J5 denominator for all genes in that quantile.[@b34-cin-6-0389]

Intensity scaled J5
-------------------

The Intensity Scaled J5 is similar to the segmented J5 but scaled using one of the mean values (in case vs. control comparisons, the control comparison).[@b34-cin-6-0389]

D1 Test
-------

The D1 test is a twice-iterated J5 test where the remaining genes are tested after removing the initially discovered significant genes during the first iteration.[@b29-cin-6-0389]

Results
=======

Because we were most interested in relative efficiency where N3≪M, we compared methods over a range N3 = 0--250 for all tests. Three separate Efficiency Analyses were performed for the lung adenocarcinoma data: 1) 'BETWEEN' datasets, 2) 'BEER only', and 3) 'BHATTACHARJEE only'. Two classifications were performed: 1) Beer---training/test with Bhattacharjee as a validation set, and 2) Bhattacharjee---training/test with Beer as the validation set.

Efficiency analysis
-------------------

### Best test 'BETWEEN' the datasets

In this exercise we compared the genelists from Beer et al. and Bhattacharjee et al. Efficiency Analysis was performed to determine the most consistent test. Under our criterion of efficiency, the D1 and J5, appeared to produce similar results over a range of \<1000 genes. While apparently far superior to the other tests as well as random feature selection ([Fig. 2A](#f2-cin-6-0389){ref-type="fig"}, [Appendix B1](#f12-cin-6-0389){ref-type="fig"}) within the \<2500 gene range, the D1 and J5 were also superior in our range of interest (0--250) ([Fig. 2B](#f2-cin-6-0389){ref-type="fig"}, [Appendix B2](#f13-cin-6-0389){ref-type="fig"}). Further exploration of normalization was performed using the D1 test only.

Corrections for the intensity-related bias we observed did not influence the results greatly (for example, compare J5 to Segmented (Seg J5; [Appendix B3](#f14-cin-6-0389){ref-type="fig"}). The results showed that the Intensity Scaled J5 seemed to be most consistent over the lower range of genes, 0--2000 genes. Other tests outperformed at higher values of N3, but not until several thousands of genes were included ([Appendix B1](#f12-cin-6-0389){ref-type="fig"} and [B3](#f14-cin-6-0389){ref-type="fig"}), however, the D1, J5, and Segmented J5 outperformed Random Feature Selection greatly, and appeared to be the most consistent test at a lower number of desired genes.

Most efficient transformation/normalization methods, both datasets
------------------------------------------------------------------

To study the effects of competing normalization effects on the efficiency of the D1 test, we generated efficiency curves for the D1 test under a variety of normalization methods. The locally optimized overlap at low N3 for the D1 test alone was 41.4% and occurred at 47 genes. [Figure 3](#f3-cin-6-0389){ref-type="fig"} shows the results from the normalization comparisons. Although none of the normalization methods led to marked improvement, ([Appendix B4](#f15-cin-6-0389){ref-type="fig"} and [B5](#f16-cin-6-0389){ref-type="fig"}), the quantile normalizations appeared to improve overlap results slightly over our gene range (0--100). Quantiles 25, 75, and 99 all performed best at some point over the gene range. Therefore the "best" method of normalization depends on the number of genes in question. The Efficiency Analysis results from D1 alone improved minimally using these normalizations ([Fig. 3](#f3-cin-6-0389){ref-type="fig"}).

Most internally efficient methods, BEER dataset
-----------------------------------------------

We split the Beer dataset randomly three times producing four independent, representative sample groups. Each group produced a gene list from the two populations (normal-cancer). As before, Efficiency Analysis was performed to determine the most efficient test. The D1, J5, and Segmented J5 all appeared to give similar results over the specified range of genes (0--250), while being far superior to the other tests as well as random feature selection ([Fig. 4A](#f4-cin-6-0389){ref-type="fig"}, [Appendix B6](#f17-cin-6-0389){ref-type="fig"}). To reduce the slight variation in performance associated with any arbitrary split, each of the most efficient tests were re-analyzed 3-fold ([Fig. 4B](#f4-cin-6-0389){ref-type="fig"}). Because the D1 test was evidently the most efficient test for this dataset (independent of intensity-scaling), further exploration of normalization was performed using the D1 test only.

As before, we wanted to assess the transformation/normalization methods to see if, when used in combination with the D1 test, the percent overlap results would improve. The maximum overlap for the D1 test alone was 35% and occurred around 46 genes. The Z transform normalization method appeared to be most consistent over the entire range of genes (0--250). With Z transformation, the highest percent overlap occurred at 42 genes ([Fig. 5](#f5-cin-6-0389){ref-type="fig"}, [Appendix B7](#f18-cin-6-0389){ref-type="fig"}), with 21 of the genes being present on all lists 100% of the time ([Appendix C](#app3-cin-6-0389){ref-type="app"}, [Table A](#t1-cin-6-0389){ref-type="table"}). The normalization method increased O to almost 46% ([Fig. 5](#f5-cin-6-0389){ref-type="fig"}, [Appendix B7](#f18-cin-6-0389){ref-type="fig"}).

Most internally efficient methods, BHATTACHARJEE dataset
--------------------------------------------------------

Again, Efficiency Analysis was performed to determine the most consistent test. As before, the D1, J5, and Segmented J5 all appeared to give similar results over the specified range of genes (0--125), while being superior to the other tests as well as random feature selection ([Fig. 6](#f6-cin-6-0389){ref-type="fig"}, [Appendix B8](#f19-cin-6-0389){ref-type="fig"}). Again, these three tests were re-analyzed at 3-fold ([Fig. 6](#f6-cin-6-0389){ref-type="fig"}), with all three D1 tests most efficient. Next, the transformation/normalization methods were tested. The maximum overlap for the D1 test alone was 28.7% and occurred around 101 genes (\~100 genes desired).

The results from the normalization comparisons are summarized as [Figure 7](#f7-cin-6-0389){ref-type="fig"}, [Appendix B9](#f20-cin-6-0389){ref-type="fig"}. The Trimmed mean 5%--95% normalization method outperformed all others over almost the entire range of genes (0--250). With TM 5%--95%, the highest percent overlap occurred at 102 genes, with 32 of the genes being present on all lists 100% of the time ([Appendix C](#app3-cin-6-0389){ref-type="app"}, [Table C](#t3-cin-6-0389){ref-type="table"}). The normalization method increased the O to 29.2%.

Classification
--------------

### Classification of the Beer dataset

#### Initial training using Beer dataset

The training and test error results using RRV (10 resampling iterations) for the Beer dataset also indicated that D1 might be most useful. The D1 (J5 family) test appeared to produce the lowest test Achieved Classification Error (ACE) requiring only 4 genes, at a threshold of 31.0 (see [Appendix D](#app4-cin-6-0389){ref-type="app"}). The test ACE was \~19% using the D1 alone ([Fig. 8](#f8-cin-6-0389){ref-type="fig"}, [Appendix B10](#f21-cin-6-0389){ref-type="fig"}) and improved to 18.4% with the Quantile 99 normalization method ([Fig. 9](#f9-cin-6-0389){ref-type="fig"}, [Appendix B11](#f22-cin-6-0389){ref-type="fig"}). Importantly, both the test and the normalization methods were predicted to be most efficient! The threshold value with maximum overlap at N3≪N was used without RRV for classification of individual samples for each test. The results were as follows: A between-mean array correlation after normalization of 0.984, the between array coefficient of variation (COV) of 0.034 before normalization, and 0.062 after normalization, and a confounding index (CI; compares the average within-group correlation to the average between-group correlation; The CI should be as close to 1.0 as possible, values higher than 1.0 may indicate incidental confounding in the experimental design[@b21-cin-6-0389]) of 1.007 both before and after normalization. The combined score values from the four genes correctly classified 84.8% of the samples correct on average, with a sensitivity of 0.47 and a specificity of 0.942. For the PACE Analysis, the D1 test with Quantile 99 normalization and a threshold of 31 was used. 100 iterations were performed over a threshold of 0--15 with a step of 0.5. The findings were not significant based on PACE Analysis ([Appendix B14](#f25-cin-6-0389){ref-type="fig"}).

#### Bhattacharjee external validation dataset

The data from only the four genes ([Appendix B15](#f26-cin-6-0389){ref-type="fig"}) of interest from the Beer dataset were retained from the Bhattacharjee dataset, and the classification performed without normalization. The ACE, sensitivity, and specificity can be found in [Appendix C](#app3-cin-6-0389){ref-type="app"}, [Table B](#t2-cin-6-0389){ref-type="table"}. The best externally valid results were as follows: 79.7% of samples were classified correctly, with a sensitivity of 0.352, and a specificity of 0.942. Again, PACE Analysis was performed with the D1 test, Quantile 50 normalization, over a range of 0--10 with a step of 0.5. PACE Analysis of the test set again appeared not to be significant ([Appendix B14](#f25-cin-6-0389){ref-type="fig"}). Xi et al.[@b35-cin-6-0389] examined the same datasets for classification by lymph node status using PAM.[@b36-cin-6-0389] The Beer dataset was used for training, utilizing 318 genes, and Bhattacharjee was used as an external validation set, as we have done here. They reported test lymph node positive accuracy at 94.1%, but a lymph node negative accuracy of only 21.2%, and an overall test classification accuracy of 39.1% for the Bhattacharjee dataset.

### Classification of the Bhattacharjee dataset

The same methods and techniques were performed for cross-validation of the datasets.

#### Initial training using Bhattacharjee dataset

Random Resampling Validation (RRV) was performed on the Bhattacharjee et al. dataset with the same parameters as before. The results (test ACE) without and with normalization are shown in [Figures 10](#f10-cin-6-0389){ref-type="fig"} and [11](#f11-cin-6-0389){ref-type="fig"}, respectively. QC statistics were: between-mean array correlation after normalization of 0.996, the between array coefficient of variation (COV) of 0.028 before normalization, and 0.0030 after normalization, and a confounding index (CI) of 0.997 before and 0.998 after normalization. The lowest Achieved Classification Error (ACE) was 32.0% ([Fig. 10](#f10-cin-6-0389){ref-type="fig"}, [Appendix B12](#f23-cin-6-0389){ref-type="fig"}), was achieved using the N fold Ratio test, with six retained genes, at a threshold of 0.37 (see [Appendix C](#app3-cin-6-0389){ref-type="app"}). This threshold was then used without RRV to classify individual samples. The combined score values from the six genes correctly classified 73.9% of the samples correctly, with a sensitivity of 0.235 and a specificity of 0.903. For the PACE Analysis, the N fold ratio test with SGM-Square Root normalization ([Fig. 11](#f11-cin-6-0389){ref-type="fig"}, [Appendix B13](#f24-cin-6-0389){ref-type="fig"}) and a threshold of 0.34 was used. 100 iterations were performed over a threshold of 0--10 with a step of 0.5. The PACE Analysis appeared to show findings that are not significant ([Appendix B16](#f27-cin-6-0389){ref-type="fig"}).

#### Beer external validation dataset

The data from only the six returned genes ([Appendix B17](#f28-cin-6-0389){ref-type="fig"}) from the Bhattacharjee dataset were removed from the Beer dataset, and the classification performed with all normalizations. The externally valid results were as follows: 70.9% of samples were classified correctly, with a sensitivity of 0.411, and a specificity of 0.782. Again, PACE Analysis was performed with the N fold ratio test and SGM-Square Root normalization (as well as SGM-Log 2, not shown), over a range of 0--8 with a step of 0.5. PACE Analysis of the test set again seemed to show not significant findings ([Appendix B16](#f27-cin-6-0389){ref-type="fig"}). Additionally, the D1 test was performed with and without normalization and produced very similar results to the N fold ratio classification. Xi et al.[@b35-cin-6-0389] reported the following findings: a test lymph node classification error of 70% for pathology-positive, and 38% for pathology-negative patients, and an overall cross-validated accuracy of 54%. Note that here the Bhattacharjee dataset was used for training, utilizing 318 genes, and Beer was used as an external validation set.

Discussion
==========

Microarray technologies generate large volumes of potentially useful information and there have been many papers that have described tools and approaches for data analysis. Unfortunately the relative performance of the methods implemented, in the majority of available tools have not been compared extensively. We report on Efficiency Analysis, which we envision could possibly be an early step in a standardizing procedure for micro-array data analysis. The Efficiency Analysis described in this paper is based on the assumption that the most consistent test will provide the greatest amount of overlap at a fixed number of genes. We leave open the question of where the comparisons of the curves might be most meaningful, because this may depend entirely on the biology of a given study or investigation. An important advantage of this approach is that the identity of the genes are not examined in the comparison of different methods, thereby removing any possibility of imposing a biological bias in favoring one result over others.

Choe et al. (2005) used a control dataset to evaluate different methods. Their study was more focused on combinations of normalization/transformation/tests for differential expression, but really only compared three tests for differential expression (t-test, Cyber T, and SAM).[@b37-cin-6-0389] We have shown that if the appropriate test is chosen first, transformations/normalizations may alter the accuracy of the results but not substantially. The only real difference is that our method chooses and assesses the test first, where Choe's method follows a more classical progression of background correction to normalization to choosing the test last. By assessing the test at the beginning of the process, biases or other complications arising due to background subtraction, transformation/normalization, and/or other variability may be avoided. Thus no "standard" method of data analysis currently exists and no approach has been described for determining the most efficient method for analysis of a given dataset.

The success of any research lies on reproducibility of results, as does Efficiency Analysis. Dividing the dataset into additional variable groups a number of times had no significant effect on the results obtained (data not shown), suggesting that the Efficiency Analysis using the D1 test was robust. There is an issue of intensity-related bias in some tests for a certain number of genes, and this factor may impact Efficiency Analysis. The Segmented J5 and Intensity Scaled J5 were created to further study, and may alleviate that problem ([Appendix B3](#f14-cin-6-0389){ref-type="fig"}). By looking at the dataset over pre-assigned quantiles, the bias is addressed. The effects of this bias are evidently minimized by the Intensity Scaled J5 test ([Appendix B3](#f14-cin-6-0389){ref-type="fig"}), and do not significantly affect the results. The variation in performance among the different tests that we see has profound implications for studies that seek to determine whether a unique gene set might exist for a given clinical diagnosis, such as in breast cancer, and for metaanalysis.[@b38-cin-6-0389] Any metaanalysis of microarray data that simply uses the t-test, for example, without attempting to determine first which of the scores of tests for finding differentially expressed genes might provide the highest true positive rate will be prone to find vast differences among studies.

In this study, only single normalization methods were considered (no combinations). There very well may be a combination of transformation/normalization methods that would produce better results than any of those tested in this study. Also, Naïve Bayes was the only classifier tested in our study. It may be that other classifiers will produce even better accuracy (e.g. PAM[@b36-cin-6-0389], SVM[@b39-cin-6-0389], CART[@b40-cin-6-0389], etc.)

The classification results were considered taking a combination of performance characteristics and parameters into account (number of samples classified correctly, sensitivity, specificity, and number of genes). Classifying one test as the most consistent could vary depending on the parameter that is considered the most important. For our purposes, a minimal gene number, a low percent of classification error, high sensitivity and specificity were all considered in deciding which methods produced the 'most consistent' classification. We recognize that there are many biological factors (e.g. age, smoking history, weight, sex, diet, and environmental exposures), each of which could have influenced the performance of the test significantly. We only stratified the cases into neoplastic and non-neoplastic groups, and did not take into consideration the potential effect of influences such as those listed above, or the presence of other complex diseases. Also, there very well could be misclassification of the samples involved, of which we are unaware.

There is disappointment that accompanies the classification results not being significant according to PACE Analysis. Compared to other analyses using PAM[@b36-cin-6-0389] (i.e. Xi et al. 2005), who achieved impressive classification errors (training accuracy of 88.4% when compared to pathology), we find our RRV results reassuring in that they were predicted by Efficiency Analysis. It may simply not be possible to differentiate normal lung tissue and adenocarcinoma tissue based solely on a few genes with the data and samples that were used. Xi et al. used a 318-gene set, with generally the same samples (15 omitted from the test set), to discriminate samples based on lymph node status and although the training errors were significant, the overall test validation accuracy was 39.1% (Beer-train, Bhattacharjee-test) and a cross-validated 54% (Bhattacharjee-train, Beer-test). In our study, the final classifications were the product of the test/normalization combination that produced the lowest test classification error for the existing methods. The several genes that appear to be consistently differentially expressed may be of interest in lung adenocarcinoma. Three of the genes of interest appear to be closely related which will lead to further investigation. TFF3, CALCA, and PCSK1 all are listed by Bhattacharjee et al. as genes of interest in cluster C2 (an adenocarcinoma subclass). Of the remaining genes, only HLA-B appeared as being significant in other lung carcinoma papers investigated.[@b9-cin-6-0389],[@b13-cin-6-0389],[@b41-cin-6-0389],[@b42-cin-6-0389]

Sample and patient classification is an important goal. We are encouraged by Efficiency Analysis' ability to somewhat determine the "best" performing test and normalization methods to use for classification in a way that is independent of generating the classification, with the Beer dataset. For the Bhattacharjee dataset, N fold ratio produced the best classification using RRV, but it is important to note that when D1 was independently used for classification it produced very similar results. D1 and J5 ranked second and third. When compared to the Beer dataset, the Bhattacharjee dataset appeared to be 'less consistent'. This may be due to experimental or biological effects, but we cannot say for certain. Obviously further investigation is required. External Efficiency Analysis is available through the Overlap4 tool, and internal Efficiency Analysis is automated in caGEDA under "Computational Validation" options. We invite others to participate in using caGEDA and Efficiency Analysis using their own datasets.

During the preparation of this manuscript, the Rat toxicogenomic MAQC study was released in Nature Biotechnology.[@b28-cin-6-0389] Guo et al. assessed the concordance in inter-site and cross-platform comparisons and the impact of gene selection methods on the reproducibility of profiling data in terms of differentially expressed genes.[@b28-cin-6-0389] In order to validate their findings, the authors used percent overlap of gene lists, between different laboratories and/or platforms, as their evaluation method. They concluded the same as we did (prior to reading their report) that, gene lists generated by fold-change were more reproducible than those obtained by t-test or SAM.[@b28-cin-6-0389] Additionally, conclusions reported by Guo et al. further support our claims as well: 1) Criteria used to define differentially expressed genes can have a dramatic impact on the overlap of the resulting genelists, 2) Findings are reproducible across laboratories and platforms when the preferred gene selection criteria are used, 3) Normalization methods do not alter the gene lists unless a p-value criterion is involved in gene selection, 4) Fold-change performed the best, followed by SAM and lastly the t-test (with mention of the problems with gene selection methods based solely on t-test p-values), 5) The importance of appropriate data analysis procedure as a whole (and may we add the order).[@b28-cin-6-0389]

Efficiency analysis was performed on the Rat toxicogenomic study data, the results of which can be seen in [Appendix E](#app5-cin-6-0389){ref-type="app"}. In support of our previous conclusions, the J5 performed best overall, better than fold-change, and the t-test performed poorly in almost all situations. We believe that including an analysis of the MAQC Rat toxicogenomic data should clarify some doubt as to whether Efficiency Analysis' has ability to predict the 'best test'. Although the results were minimally platform-dependent, we believe that our previous assertions are further supported by these results. We extend their findings and add that under a similar criterion, the J5 was more reproducible than fold change.

Our interpretation of the results must be stated with important caveats. Absent independent validation, for example, by RT-PCR, it may be premature to conclude the relative order of the reproducibility and consistency of the methods explored.

In conclusion, Efficiency Analysis appears to distinguish among tests that are incapable of providing consistent results and seems to also be able to generally predict which feature selection methods yield the lowest sample classification error. Although not always correct, the method does produce, if not the 'best' test, a general understanding of which tests yield similar internally and externally consistent results. We were surprised by the consistently poor performance of the t-test and variants of that test. We urge caution in the use of estimates of variance derived from small sample sets in high dimensions, and finding differentially expressed genes in solid tumors using tests derived from second central moment estimates.[@b30-cin-6-0389] Note the J5 and related tests avoid the use of estimated variance altogether. The D1 test gave the highest percent overlap in both datasets, and although the results were validated by independent datasets, the features selected did not lead to a significant Naïve Bayes classifier, but then neither did most other gene lists from other tests. This may be due to intrinsic molecular heterogeneity within lung cancer; the Naïve Bayes model, like other fixed-marker intensity input additive linear models, uses all genes for all patients. Research is needed on classifiers that are robust to the intrinsic molecular heterogeneity of cancers.

The authors are extremely thankful for the published datasets of Beer et al. University of Michigan, and Bhattacharjee et al. Harvard University, and the MAQC Project, and acknowledge the support and valuable suggestions received from the Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, and the Windber Research Institute (WRI), Windber, PA. WRI is also acknowledged for providing the opportunity and financial support for graduate study. Dr. Richard Somiari, ITSI-Biosciences; Mr. Nick Jacobs, Dr. Stella Somiari, and Dr. Michael Liebman, WRI; Dr. Vanathi Gopalakrishnan and Dr. Wendy Chapman, CBMI; and Dr. Milos Hauskrecht, University of Pittsburgh, Computer Science Department are acknowledged for significant reviews, comments, contributions, and support offered.

The following descriptions taken from the caGEDA website:

Threshold-based tests
=====================

J5: compares the difference of means in any gene to the average difference in means over the whole array.

D1: performs the J5 once, removes all significant genes, and performs the J5 again to capture any genes that were missed initially.

Signal-to-Noise: similar to t test with a high positive false discovery rate.

Segmented J5: developed out of concern over intensity-related bias in the tests. The segmented J5 was designed to determine whether the J5 test was more efficient than the other tests when the denominator was calculated only using genes with similar intensity. In the segmented J5, genes are ranked by median intensity and a number of quantiles are determined. The mean of the absolute value of the difference of means is used for each gene within a quantile as the J5 denominator.

Intensity Scaled J5: similar to segmented J5 but scaled using the entire range of intensities.

Normalization methods
=====================

Within-array
------------

Sum: all intensity values on the array are multiplied by the sum of all intensity values on the array.

Mean: all intensity values on the array are multiplied by the mean of all intensity values on the array.

Median: all intensity values on the array are multiplied by the median of all intensity values on the array.

Quantile/Percentile: all intensity values on the array are multiplied by the mean of all intensity values on the array beyond the specified quantile.

Trimmed mean: all intensity values on the array are multiplied by the mean of all intensity values on the array between two specified quantiles.

Among-array
-----------

Median mean: the mean intensity of each array is calculated, the median mean is identified, and an array-specific multiplicative factor is defined as the ratio of that array's mean to the median mean

Minimum mean: same as median mean but instead of normalizing to the median mean, the scaling factor is the minimum mean of all of the arrays.

Global mean adjustment: the global mean intensities of all arrays are calculated, then the difference between each individual array mean and the global mean is calculated, the array-specific difference value is then added to or subtracted from each individual expression intensity value on an array and the result is that all arrays now have the same overall mean.

Max1, Min0: re-scales each expression intensity profile so the array-specific maxima and minima are equal in all arrays.

Z-transformation: similar to log transformation in that it can change the shape of the distribution, but can reduce performance of some tests for differentially expressed genes.

![Efficiency plot of statistical tests performed without normalization\
The entire gene range is shown. The J5 and D1 far outperform others based on amount of overlap. The above is a comparison of O (% overlap) vs. N3 (number of genes). The results are from overlap of the Beer and Bhattacharjee significant gene lists. Abbreviations are as follows: BSS-WSS: Between Sum of Squares, Within Sum of Squares; IntSc J5: Intensity Scaled J5; N fold: \[(M1−M2)/M2\]; N fold Ratio 1: Ratio of Mean; PPST: Permutation Percentile Separability; PVT: Pooled Variance t Test; RFS: Random Feature Selection; SAM: Significance Analysis of Microarray; SegJ5: Segmented J5; SST: Simple Separability Test; SN: Signal to Noise Ratio; WL: Wilks Lambda Test.](cin-6-0389f12){#f12-cin-6-0389}

![Efficiency plot of statistical tests performed without normalization\
A gene range of 0--250 is shown. The J5 and D1 far outperform others based on amount of overlap. The above is a comparison of O (% overlap) vs. N3 (number of genes). The results are from overlap of the Beer and Bhattacharjee significant gene lists. Abbreviations are as follows: BSS-WSS: Between Sum of Squares, Within Sum of Squares; IntSc J5: Intensity Scaled J5; N fold: \[(M1−M2)/M2\]; N fold Ratio 1: Ratio of Mean; PPST: Permutation Percentile Separability; PVT: Pooled Variance t Test; RFS: Random Feature Selection; SAM: Significance Analysis of Microarray; SegJ5: Segmented J5; SST: Simple Separability Test; SN: Signal to Noise Ratio; WL: Wilks Lambda Test.](cin-6-0389f13){#f13-cin-6-0389}

!['Pre-normalized' plots from within gene corrected data\
The Intensity Scaled J5 is superior at lower number of genes. The reduction in efficiency in many tests provides evidence that the apparent bias does exist for those methods, but their relative ranking does not alter significantly the interpretation of the results.](cin-6-0389f14){#f14-cin-6-0389}

![Efficiency plot of transformation/normalization methods\
The 0--100 gene range, comparing the Beer and Bhattacharjee datasets, is shown. Based on this figure alone it doesn't appear that any normalization method improves the D1 efficiency. However, a closer look where N3≪m ([Figure 2](#f2-cin-6-0389){ref-type="fig"}) reveals that a few methods actually do improve efficiency.](cin-6-0389f15){#f15-cin-6-0389}

![Efficiency plot of normalization and transformation methods\
The D1 test was used with all methods. Again, the above results are from a comparison of O (% overlap) vs. N3 (number of genes). The results are from overlap of the Beer and Bhattacharjee significant gene lists. Q: Quantile Normalization utilizing quantiles; TM: Trimmed Mean utilizing quantiles; GMA: Global Mean Adjustment; 5%--95%: Global Quantile Normalization utilizing the 5th--95th quantiles; SGM-CondLog: Subtract Global Minimum, Conditional Log Transformation. The Subtract Global Minimum procedure was performed to eliminate negative values and allow for log and square root.](cin-6-0389f16){#f16-cin-6-0389}

![Efficiency plot of statistical tests performed without normalization for the Beer dataset\
Only the 0--150 gene range is shown. Certain tests appear to be more consistent depending on the number of genes desired, but a few outperform all others over the given range. The above results are from a comparison of O (% overlap) vs. N3 (number of genes). The results are from overlap of the Beer significant gene lists. O is percent overlap; N3 is the number of genes.](cin-6-0389f17){#f17-cin-6-0389}

![Efficiency plot of normalization and transformation methods for the Beer dataset\
The above results are from a comparison of O (% overlap) vs. N3 (number of genes). The results are from overlap of the Beer significant gene lists. The D1 test was used with all available methods. It is apparent that the Z transformation appeared to produce the greatest overlap over most of the given range (0--125 genes), but others appeared optimal at the extreme low end.](cin-6-0389f18){#f18-cin-6-0389}

![Efficiency plot of statistical tests performed without normalization for the Bhattacharjee dataset\
The above results are from a comparison of O (% overlap) vs. N3 (number of genes). The results are from overlap of the Bhattacharjee significant gene lists. Only the 0--125-gene range is shown. The J5 family of tests appeared to be most efficient.](cin-6-0389f19){#f19-cin-6-0389}

![Efficiency plot of normalization and transformation methods for the Bhattacharjee dataset\
The above results are from a comparison of O (% overlap) vs. N3 (number of genes). The results are from overlap of the Bhattacharjee significant gene lists. The D1 test was used with all normalization methods. The Subtract Global Minimum procedure was performed to eliminate negative values and allow for log and square root transformations. At 100 genes, TM 5%--95% was the best normalization method.](cin-6-0389f20){#f20-cin-6-0389}

![Test ACE for tests using Beer dataset\
As can be seen, the best ACE (19.4%) was found using the D1 test at around 3--4 genes. The second and third performers were also from the J5 family, which was consistent with Efficiency Analysis results.](cin-6-0389f21){#f21-cin-6-0389}

![RRV estimated ACE under various normalization methods\
The D1 test was performed with all transformation/normalization methods. Also consistent with Efficiency Analysis is that the Quantile 99 method again produces the most efficient results (18.45%) in combination with D1.](cin-6-0389f22){#f22-cin-6-0389}

![Test ACE for tests using Bhattacharjee\
As can be seen, the best ACE (30.7%) was found not using the D1 test, but the N fold ratio test. The J5 and D1 performed second and third best for this data set at 3--4 genes. This finding is not consistent with Efficient Analysis.](cin-6-0389f23){#f23-cin-6-0389}

![RRV estimated ACE scores for various normalizations from the Bhattacharjee dataset\
The N fold ratio test was performed with all transformation/normalization methods.](cin-6-0389f24){#f24-cin-6-0389}

![Training set Random Resampling Validation and PACE plots\
The lowest classification error, for the Beer dataset, was 18.4% at a threshold of 31.0, requiring only 4 genes on average. PACE Analysis showed that the findings did not appear to be significant. This is made apparent by the red line (black beaded line) never intersecting the blue 95% line.](cin-6-0389f25){#f25-cin-6-0389}

![Score histogram and Expression Grid plot of significant genes found using the D1 score at a threshold of 31.0\
Results are from the Beer dataset. The score histogram shows the gene regulation based on the test score, the expression pattern grid is a heat map of expression values over each sample, separated by class.](cin-6-0389f26){#f26-cin-6-0389}

![Training set Random Resampling Validation and PACE plots\
The best achieved classification error, for the Bhattacharjee dataset, was 32.0% at a threshold of 0.37, requiring five genes. The PACE Analysis shows that the findings did not seem significant. This is made apparent by the red line (thick black line) never falling below the blue 95% line.](cin-6-0389f27){#f27-cin-6-0389}

![Score histogram and Expression Grid plot of significant genes found using the N fold Ratio score at a threshold of 0.37\
Results are from the Bhattacharjee dataset.](cin-6-0389f28){#f28-cin-6-0389}

###### Genelist from efficiency analysis of both datasets

\% found = percentage of time that the gene was found on all gene lists from all data splits.

       Beer-      GenBank              \#   Bhattacharjee-Gene   GenBank                      Bhattacharjee-Gene   GenBank     
  ---- ---------- ----------- -------- ---- -------------------- -------------- -------- ---- -------------------- ----------- --------
  1    ALDOA      NM_000034   100      1    ALDH1                NM_000689      100      44   CEBPB                NM_005194   66.666
  2    COL1A1     NM_000088   100      2    ASCL1                NM_004316      100      45   CLIC1                NM_001288   66.666
  3    COL5A2     NM_000393   100      3    B2M                  NM_004048      100      46   MMP11                NM_005940   66.666
  4    GAPD       NM_002046   100      4    BGN                  NM_001711      100      47   MSN                  NM_002444   66.666
  5    JUND       NM_005354   100      5    CLU                  NM_001831      100      48   APOC1                NM_001645   66.666
  6    KIAA0220               100      6    COL1A2               NM_000089      100      49   BENE                 NM_005434   66.666
  7    LGALS1     NM_002305   100      7    CYP2B                               100      50   COL3A1               NM_000090   66.666
  8    MGP        NM_000900   100      8    FOXG1A               NM_005249      100      51   PFN1                 NM_005022   66.666
  9    PTGDS      NM_000954   100      9    FTL                  NM_000146      100      52   PGAM1                NM_002629   66.666
  10   RPL37      NM_000997   100      10   FXYD5                NM_144779      100      53   PTGDS                NM_000954   66.666
  11   RPLP0      NM_053275   100      11   IFI27                NM_005532      100      54   COL6A1               NM_001848   66.666
  12   RPLP1      NM_001003   100      12   LDHB                 NM_002300      100      55   RPL18                            66.666
  13   RPS23      NM_001025   100      13   MDK                  NM_001012334   100      56   RPL27A               NM_000990   66.666
  14   S100A10    NM_002966   100      14   MIF                  NM_002415      100      57   RPL29                NM_000992   66.666
  15   S100A11    NM_005620   100      15   NBL1                 NM_182744      100      58   RPL3                             66.666
  16   S100A9     NM_002965   100      16   NK4                  NM_001012631   100      59   APOE                 NM_000041   66.666
  17   S100P      NM_005980   100      17   PCSK1                NM_000439      100      60   CRIP1                NM_001311   66.666
  18   SLPI       NM_003064   100      18   RNASE1               NM_002933      100      61   RPS15A               NM_001019   66.666
  19   SPARC                  100      19   RPLP1                NM_001003      100      62   CYBA                 NM_000101   66.666
  20   TMSB4X     NM_021109   100      20   RPS10                NM_001014      100      63   RPS20                NM_001023   66.666
  21   VIM        NM_003380   100      21   RPS2                 NM_002952      100      64   RPS21                NM_001024   66.666
  22   CST3       NM_000099   66.666   22   RPS24                NM_033022      100      65   ACTG1                NM_001614   66.666
  23   OAZ1       NM_004152   66.666   23   S100A10              NM_002966      100      66   DIA4                 NM_000903   66.666
  24   CSTB       NM_000100   66.666   24   SEPW1                NM_003009      100      67   S100A8               NM_002964   66.666
  25   RPL18      NM_000979   66.666   25   SHC1                 NM_003029      100      68   SELENBP1             NM_003944   66.666
  26   RPL3       NM_000967   66.666   26   SLPI                 NM_003064      100      69   DUSP4                NM_057158   66.666
  27   EEF2       NM_001961   66.666   27   SPARC                NM_003118      100      70   SFTPB                NM_000542   66.666
  28   FN1        NM_212476   66.666   28   SPP1                 NM_001040058   100      71   SFTPD                NM_003019   66.666
  29   ACTB       NM_001101   66.666   29   TAGLN2               NM_003564      100      72   EIF4G2               NM_001418   66.666
  30   RPS11      NM_001015   66.666   30   TFF3                 NM_003226      100      73   EPHX1                NM_000120   66.666
  31   HE1        NM_006432   66.666   31   TMSB10               NM_021103      100      74   FLJ20493             NM_019051   66.666
  32   RPS28      NM_001031   66.666   32   YWHAH                NM_003405      100      75   SPINK1               NM_003122   66.666
  33   RPS8       NM_001012   66.666   33   COL6A2               NM_001849      88.888   76   FOSB                 NM_006732   66.666
  34   HLA-B      NM_005514   66.666   34   BF                   NM_001710      77.777   77   BIG2                 NM_006420   66.666
  35   HLA-DRA    NM_019111   66.666   35   H2AFO                NM_003516      66.666   78   FTH1                 NM_002032   66.666
  36   HLA-DRB1   NM_02124    66.666   36   HE4                  NM_006103      66.666   79   TGFBI                NM_000358   66.666
  37   IGKC                   66.666   37   HLA-A                NM_002116      66.666   80   C1QB                 NM_000491   66.666
  38   SFTPB      NM_198843   66.666   38   HSPD1                NM_199440      66.666   81   UGB                  NM_003357   66.666
  39   SFTPD      NM_000542   66.666   39   CCND1                NM_053056      66.666   82   VIM                  NM_003380   66.666
  40   COL1A2     NM_000089   66.666   40   IGFBP3               NM_001013398   66.666   83   CALCA                NM_001741   66.666
  41   COL3A1     NM_000090   66.666   41   IGL@                                66.666   84   GPX4                 NM_002085   55.555
  42   TAGLN2     NM_003564   66.666   42   CEACAM6              NM_002483      66.666   85   LTA4H                NM_000895   55.555
                                       43   LGALS1               NM_002305      66.666   86   TEGT                 NM_003217   55.555

###### 

Bhattacharjee dataset used for external validation of the beer dataset classifier.

  Norm method             \% Correct   Sensitivity   Specificity   Between-mean array correlation(after normalization)   Between array coefficient of variation (after normalization)   Confounding index (after normalization)
  ----------------------- ------------ ------------- ------------- ----------------------------------------------------- -------------------------------------------------------------- -----------------------------------------
  Quantile 50             0.797        0.352         0.942         0.993                                                 0.207                                                          0.994
  SGM-Log2                0.782        0.176         0.98          0.999                                                 0.069                                                          0.998
  Max1, Min0              0.768        0.058         1             0.998                                                 0.126                                                          0.994
  SGM-Square Root Trans   0.768        0.058         1             0.999                                                 −1.103                                                         0.999
  5%--95% Adjust          0.753        0             1             0.998                                                 0.173                                                          0.994
  SGM-Cond Log Trans      0.753        0.058         0.98          0.999                                                 0.38                                                           1
  Global Mean Adjust      0.753        0             1             0.999                                                 0                                                              0.994
  Mean                    0.753        0.117         0.961         0.997                                                 0                                                              0.994
  Minimum Mean            0.753        0.117         0.961         0.997                                                 0                                                              0.994
  Quantile 25             0.753        0.117         0.961         0.997                                                 0.398                                                          0.994
  Quantile 75             0.753        0.117         0.961         0.998                                                 0.154                                                          0.994
  Quantile 90             0.753        0.117         0.961         0.998                                                 0.154                                                          0.994
  Quantile 95             0.753        0.117         0.961         0.998                                                 0.154                                                          0.994
  Quantile 99             0.753        0.117         0.961         0.998                                                 0.154                                                          0.994
  Sum                     0.753        0.117         0.961         0.997                                                 0                                                              0.994
  Median                  0.739        0.117         0.942         0.994                                                 0.178                                                          0.994
  Median Mean             0.739        0.058         0.961         0.999                                                 0.503                                                          0.994
  No Norm                 0.739        0             0.98          0.999                                                 0.246                                                          0.994
  Trimmed Mean 10--90     0.739        0.235         0.903         0.994                                                 0.218                                                          0.994
  Trimmed Mean 1--99      0.739        0.235         0.903         0.994                                                 0.218                                                          0.994
  Trimmed Mean 25--75     0.739        0.117         0.942         0.994                                                 0.178                                                          0.994
  Trimmed Mean 5--95      0.739        0.235         0.903         0.994                                                 0.218                                                          0.994
  Z Trans                 0.724        0             0.961         0.998                                                 −15.474                                                        0.994

###### 

Beer dataset used for external validation of the Bhattacharjee dataset classifier.

  Norm Method             \% Correct   Sensitivity   Specificity   Between-mean array correlation (after normalization)   Between array coefficient of variation (after normalization)   Confounding index (after normalization)
  ----------------------- ------------ ------------- ------------- ------------------------------------------------------ -------------------------------------------------------------- -----------------------------------------
  SGM-Log2                0.709        0.411         0.782         0.931                                                  0.105                                                          0.985
  Quantile 75             0.511        0.647         0.478         0.996                                                  0.807                                                          0.989
  Mean                    0.488        0.705         0.434         0.993                                                  0                                                              0.989
  Minimum Mean            0.488        0.705         0.434         0.993                                                  0                                                              0.989
  Sum                     0.488        0.705         0.434         0.993                                                  0                                                              0.989
  Z Trans                 0.476        0.647         0.434         0.992                                                  −30.447                                                        0.989
  5%--95% Adjust          0.465        0.882         0.362         0.991                                                  0.252                                                          0.989
  Global Mean Adjust      0.465        0.705         0.405         0.902                                                  0                                                              0.989
  Max1, Min0              0.465        0.882         0.362         0.991                                                  0.258                                                          0.989
  Quantile 90             0.465        0.647         0.42          0.991                                                  0.265                                                          0.989
  Quantile 95             0.465        0.647         0.42          0.991                                                  0.265                                                          0.989
  Quantile 99             0.465        0.647         0.42          0.991                                                  0.265                                                          0.989
  SGM-Square Root Trans   0.441        0.941         0.318         0.961                                                  0.372                                                          0.988
  No Norm                 0.43         1             0.289         0.902                                                  0.862                                                          0.989
  Trimmed Mean 10--90     0.418        0.764         0.333         0.987                                                  0.767                                                          0.989
  Trimmed Mean 1--99      0.418        0.764         0.333         0.987                                                  0.767                                                          0.989
  Trimmed Mean 5--95      0.418        0.764         0.333         0.987                                                  0.767                                                          0.989
  Median Mean             0.406        1             0.26          0.557                                                  2.067                                                          0.989
  Quantile 25             0.406        1             0.26          −0.721                                                 −10.2                                                          1.018
  SGM-Cond Log Trans      0.36         1             0.202         0.966                                                  0.886                                                          1.026
  Quantile 50             0.36         0.941         0.217         0.622                                                  2.417                                                          0.989
  Trimmed Mean 25--75     0.36         0.941         0.217         0.768                                                  1.915                                                          0.989
  Median                  0.348        0.941         0.202         0.694                                                  2.2                                                            0.989

Genes of interest
=================

The genes and descriptions are described below. The information was taken from The NCBI Entrez nucleotide database (<http://www.ncbi.nlm.nih.gov/entrez>) using the corresponding GenBank ID's.

**RPLP1** (NM_001003, Ribosomal protein, large, P1, transcript variant 1). (AKA: P1, RPP1, FLJ27448).

This gene encodes a ribosomal phosphoprotein that is a component of the 60S subunit and is located in the cytoplasm. It plays an important role in the elongation step of protein synthesis. The encoded protein is acidic, and its functions include RNA binding and being a structural constituent of ribosome. RPLP1 is involved in the protein biosynthesis and translational elongation processes.

**RPL37** (NM_000997, Ribosomal protein L37) (AKA: MCG99572).

This gene encodes a ribosomal protein that is a component of the 60S subunit, and is located in the cytoplasm. The protein contains a C2C2-type zinc finger-like motif.

**COL1A1** (NM_000088, Collagen, type I, alpha 1) (AKA: OI4).

This gene encodes the major component of type I collagen, found in most connective tissues, and the only component of the collagen found in cartilage. Translocations in this region may result in unregulated expression of growth factor.

**HLA-B** (NM_005514, Major histocompatibility complex, class I, B).

This class I molecule is a heterodimer (beta-2 microglobulin). Class I molecules play a central role in the immune system by presenting peptides derived from the ER lumen. Class I molecules are expressed in nearly all cells. Polymorphisms within this gene are responsible for the peptide binding specificity of each Class I molecule. HLA-B is integral to plasma membrane, and functions as a Class I receptor. HLA-B is involved in antigen processing and presentation in the immune response. HLA-B, (MHC class 1, B receptor) was found in the Beer et al. paper as one of the top 100 survival-related genes from cross-validation, found to be significantly (p = 0.000391) downregulated in Stage 3 vs. Stage 1 by 40%, but not significantly different in normal vs. tumor.

**PCSK1** (NM_000439, Proprotein convertase subtilisin/kexin type 1) (AKA: PC1, PC3, NEC1, SPC3).

Proprotein convertases process precursor proteins into their biologically active products. PCSK1 is a Type I proinsulin-processing enzyme that plays a role in regulating insulin biosynthesis. Mutations in this gene are thought to contribute to obesity, and this protein has also been associated with carcinoid tumors. PCSK1 is listed on the marker gene list by Bhattacharjee as a member of their C2 cluster subclass.

**TFF3** (NM_003226, Trefoil factor 3 (intestinal)) (AKA: ITF, TFI, HITF).

Members of the trefoil family are secretory proteins expressed in intestinal mucosa. They may protect the mucosa from insults, stabilize the mucus layer and affect healing of the epithelium. This gene is expressed in goblet cells of the intestines and colon. TFF3 is listed on the marker gene list by Bhattacharjee twice as a member of the C2 cluster subclass.

**CALCA** (NM_001741, Calcitonin/calcitonin-related polypeptide, alpha). (AKA: CT, KC, CGRP, CALC1, CGRP1, CGRP-I).

Calcitonin is a peptide hormone synthesized by the thyroid. CALCA is also listed twice on the marker gene list by Bhattacharjee as a member of the C2 cluster subclass.

**CYP2B** (NM_000767, Cytochrome P450, family 2, subfamily B, polypeptide 6) (AKA: CPB6, IIB1, P450, CYP2B6, CYPIIB6).

CYP2B, catalyzes many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein is localized to the ER and is known to metabolize some xenobiotics, such as anti-cancer drugs.

**IFI27** (NM_005532, Interferon, alpha-inducible protein 27, transcript variant a) (AKA: P27, ISG12).

**UGB** (NM_003357, Secretoglobin, family 1A, member 1 (uteroglobin)). (AKA: SCGB1A1, CC10, CC16, CCSP)).

![Efficiency plot of kidney data from the Rat toxicogenomic study\
**A**) ABI C-AA, **B**) Agilent C-AA, **C**) Affymetrix C-AA, **D**) GE C-AA. The J5 appears to perform the best over all platforms used. Dark blue: J5; pink: simple t-test; yellow: nfold1; turquoise: nfold2; purple: nfold3; black: random feature selection. AA = Aristolochic acid.](cin-6-0389f29){#f29-cin-6-0389}

![Efficiency plot of liver data from the Rat toxicogenomic study.\
**A**) ABI C-AA, **B**) Agilent C-AA, **C**) Affymetrix C-AA, **D**) GE C-AA. The J5 appears to perform quite well compared to the other methods. Dark blue: J5; pink: simple t-test; yellow: nfold1; turquoise: nfold2; purple: nfold3; black: random feature selection. AA = Aristolochic acid.](cin-6-0389f30){#f30-cin-6-0389}

![Efficiency plot of liver data from the Rat toxicogenomic study\
**A**) ABI C-C, **B**) Agilent C-C, **C**) Affymetrix C-C, **D**) GE C-C. The J5 appears to again perform quite well compared to the other methods. Dark blue: J5; pink: simple t-test; yellow: nfold1; turquoise: nfold2; purple: nfold3; black: random feature selection. C-C = Comfrey roots.](cin-6-0389f31){#f31-cin-6-0389}

![Efficiency plot of liver data from the Rat toxicogenomic study\
**A**) ABI C-R, **B**) Agilent C-R, **C**) Affymetrix C-R, **D**) GE C-R. The J5 appears to perform the best in 3 out of 4 platforms (only being outperformed by nfold1 on the Affymetrix platform). Dark blue: J5; pink: simple t-test; yellow: nfold1; turquoise: nfold2; purple: nfold3; black: random feature selection. C-R = Comfrey Roots/Riddelliine.](cin-6-0389f32){#f32-cin-6-0389}

![Venn diagram showing populations **N1** and **N2**, and the overlapping genes, **N3**.](cin-6-0389f1){#f1-cin-6-0389}

![Efficiency plot of statistical tests performed without normalization comparing the Beer and Bhattacharjee datasets\
**(A)** Over the entire gene range, and **B**) a gene range of 0--250. The J5 and D1 far outperform others based on amount of overlap. The above is a comparison of O (% overlap) vs. N3 (number of genes). The results are from overlap of the Beer and Bhattacharjee significant gene lists. **Abbreviations:** N fold Ratio: Ratio of Mean; PVT: Pooled Variance t Test; RFS: Random Feature Selection.](cin-6-0389f2){#f2-cin-6-0389}

![Efficiency plot of normalization and transformation methods of the Beer and Bhattacharjee datasets\
**A)** Over the entire gene range, and **B**) a gene range of 0--250. The D1 test was used with all methods. Again, the above results are from a comparison of O (% overlap) vs. N3 (number of genes). The results are from overlap of the Beer and Bhattacharjee significant gene lists. A close look where N3≪m ([Figure 2B](#f2-cin-6-0389){ref-type="fig"}) reveals that a few methods actually do minimally improve the efficiency. Q: Quantile Normalization; TM: Trimmed Mean; GMA: Global Mean Adjustment; 5%--95%: Global Quantile Normalization utilizing the 5th--95th quantiles; SGM-Log2: The Subtract Global Minimum procedure was performed to eliminate negative values and allow for log transformation.](cin-6-0389f3){#f3-cin-6-0389}

![Efficiency plot of statistical tests and the three most efficient tests performed without normalization from the Beer dataset\
**A)** A plot of several tests over the 0--250 gene range, and **B**) a plot of the three best performing tests over the same range. Certain tests appear to be more efficient depending on the number of genes desired, but a few outperform all others over the given range. The above results are from a comparison of O (% overlap) vs. N3 (number of genes). The results are from overlap of the Beer significant gene lists. It is apparent that the most efficient test is the D1. D1 1, 2, and 3 are three iterations of the D1 test.](cin-6-0389f4){#f4-cin-6-0389}

![Efficiency plot of normalization and transformation methods from the Beer dataset\
The above results are from a comparison of O (% overlap) vs. N3 (number of genes). The results are from overlap of the Beer significant gene lists. The D1 test was used with all available methods. It is apparent that the Z transformation appeared to produce the greatest overlap over most of the given range (0--250 genes), but others appeared optimal at the extreme low end.](cin-6-0389f5){#f5-cin-6-0389}

![Efficiency plot of statistical tests and the three most efficient tests performed without normalization from the Bhattacharjee dataset\
**A)** A plot of several tests over the 0--250 gene range, and **B**) a plot of the three best performing tests over the same range. Certain tests appear to be more efficient depending on the number of genes desired, but a few outperform all others over the given range. The above results are from a comparison of O (% overlap) vs. N3 (number of genes). The results are from overlap of the Bhattacharjee significant gene lists. It is apparent that the most efficient test is the D1. D1 1, 2, and 3 are three iterations of the D1 test.](cin-6-0389f6){#f6-cin-6-0389}

![Efficiency plot of normalization and transformation methods from the Bhattacharjee dataset\
The above results are from a comparison of O (% overlap) vs. N3 (number of genes). The results are from overlap of the Bhattacharjee significant gene lists. The D1 test was used with all normalization methods. The Subtract Global Minimum procedure was performed to eliminate negative values and allow for log transformation. At 100 genes, TM 5%--95% appeared to be the best normalization method.](cin-6-0389f7){#f7-cin-6-0389}

![Test ACE for tests using Beer dataset\
As can be seen, the best ACE (19.4%) was found using the D1 test at around 3--4 genes. The second and third performers were also from the J5 family, which was consistent with Efficiency Analysis results.](cin-6-0389f8){#f8-cin-6-0389}

![RRV estimated test ACE under various normalization methods for the Beer dataset\
The D1 test was performed with all transformation/normalization methods. Also consistent with Efficiency Analysis is that the Quantile 99 method again produces the most efficient results (18.45%) in combination with D1.](cin-6-0389f9){#f9-cin-6-0389}

![Test ACE for tests using Bhattacharjee\
As can be seen, the best ACE (30.7%) was found not using the D1 test, but the N fold ratio test. The J5 and D1 performed second and third best for this data set at 3--4 genes. This finding is not consistent with Efficient Analysis.](cin-6-0389f10){#f10-cin-6-0389}

![RRV estimated ACE scores for various normalizations\
The N fold ratio test was performed with all transformation/normalization methods. The SGM-SqRt produced the most efficient results in combination with N fold ratio (however not at the same N3 as before).](cin-6-0389f11){#f11-cin-6-0389}
